The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, applauded Congress’ important step to modernize privacy regulations affecting the disclosure of patients’ substance use disorder treatment records.

The Coronavirus Aid, Relief, and Economic Security Act (CARES) Act, which President Trump signed into law last week, includes the reintroduced, AHA-supported Protecting Jessica Grubb’s Legacy Act.

By more closely aligning 42 CFR Part 2 with HIPAA regulations, “the new law will improve the ability of hospitals and health systems to receive and share vital information necessary to provide safer, better coordinated care to patients with substance use disorder,” said AHA Executive Vice President Tom Nickels. “We applaud Congress for taking this important step, which will save lives and promote high-quality care."

Related News Articles

Headline
The Food and Drug Administration yesterday released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration…
Headline
The Department of Health and Human Services today released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results…
Headline
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they…
Headline
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten…
Headline
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group,…
Headline
The Senate yesterday approved by unanimous consent the AHA-supported Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) to allow more leeway for…